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Surnrnafy. Orexins A and B are two hypothalamic 
peptides, involved in the central regulation of feeding, 
which act through two receptor subtypes, named OXIR 
and OX2R. OXIR is selective for orexin-A, and OX2R 
binds both orexins. We have investigated the effects of 
three subcutaneous injections of 10 nmollkg body 
weight of orexins on the secretion and proliferative 
activity of immature (20-day-old) and regenerating rat 
adrenal cortex. The presence of both OXIR and OX2R 
mRNAs has been detected by reverse transcription- 
polymerase chain reaction in adult, immature and 
regenerating adrenals. Orexin-A increased corticosterone 
plasma concentration in immature rats, but not in 
animals with regenerating adrenals. Both orexins raised 
metaphase index (%o of metaphase-arrested cells) in 
immature rat adrenals, orexin-B being more effective 
than orexin-A. In contrast, both orexins equipotently 
lowered adrenal metaphase index at day 5 (but not day 
8) of adrenal regeneration. We conclude that orexins (1) 
stimulate secretion and proliferative activity of immature 
rat adrenals,  acting through OXIR and OX2R, 
respectively; and (2) do not affect secretion, but inhibit 
proliferative activity of regenerating adrenals, mainly via 
the activation of OX2R. 
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lntroduction 
Orexins A and B are two hypothalamic peptides, 
which originate from the post-translational proteolytic 
cleavage of a common precursor, called prepro-orexin. 
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Orexins act through two subtypes of G protein-coupled 
receptors, named OXIR and OX2R. OXIR is selective 
for orexin-A, while OX2R is non-selective for both 
orexins (for review, see De Lecea et al., 1998; Sakurai et 
al., 1998). 
Hypothalamic prepro-orexin mRNA was found to 
increase after 48 h of fasting (Sakurai et al., 1998), and 
orexins were shown to be mainly produced in neurons 
located in the hypothalamic areas implicated in the 
control of food intake (Bernardis and Bellinger, 1996; 
van den Po1 et al., 1998). Hence, orexins have been 
included in that group of neuropeptides, such as  
neuropeptide Y (NPY) and leptin, involved in the central 
regulation of feeding and energy homeostasis (Rohner- 
Jeanrenaud et a., 1996; Kalra, 1997; Elias et al., 1998; 
Spinedi and Gaillard, 1998; Wolf, 1998). This contention 
is also supported by findings indicating that orexin- 
immunoreactive nerve terminals originating from the 
lateral hypothalamus make synaptic contact with 
neurons of the arcuate nucleus, which not only express 
NPY, but are also provided with leptin receptors 
(Horvath et al., 1999). 
There is evidence that NPY, leptin and orexins 
control the function of the pituitary-adrenocortical axis 
in the rat (Bornstein et al., 1997; Malendowicz et al., 
1997,1998, 1999b; Nussdorfer and Gottardo, 1998). 
Since NPY and leptin were also found to enhance 
adrenocortical growth (Nussdorfer and Gottardo, 1998; 
Malendowicz et al., 1999a), we have investigated the 
effect of orexins A and B on the secretory and 
proliferative activity of immature and regenerating rat 
adrenal cortex. 
Materials and methods 
Reagents and animals 
Orexins were purchased from Peninsula 
Laboratories (St. Helene, UK), vincristin from Gedeon- 
Richter (Budapest, Hungary), and al1 other reagents from 
Sigma Chemical Co. (St. Louis, MO, USA). 
Effects of orexins on adrenals 
Adult (2-month-old) female Wistar rats and their 
offspring (20-day-old), bred in our laboratory, were kept 
under a 12:12 h light-dark cycle (illumination onset at 
8.00 a.m.) at 23 "C, and were maintained on a standard 
diet with tap water ad libitum. Under ether anaesthesia, 
the left adrenal gland of adult rats was enucleated, and 
the contralateral gland was removed. Al1 adult female 
rats were in diestrus phase, as determined by cytologic 
evaluation of vagina1 epithelium. Operated rats were 
given 0.9% NaCl to drink, and were sacrificed 5 or 8 
days after surgery. 
Reverse transcription (RT)-polymerase chain reaction 
(PCR) 
Adult, immature and regenerating adrenals were 
collected, and adult and immature glands were 
enucleated to eliminate adrenal medulla. RNA was 
extracted with the guanidium isothiocyanate method, 
and total RNA was reversed transcribed to cDNA, as 
detailed earlier (Mazzocchi et al., 2001). The 5' and 3' 
primers used for OXIR and OX2R mRNAs were 
selected according to Lopez et al. (1999). In a Delphi 
100 Thermal Cycler (Oracle Biosystem, MJ Research 
Inc., Waterston, MA, USA), we used a denaturation step 
at 95 "C for 1 min, an annealing step at 57 "C for 1 min, 
and an extension step at 72 "C for 1 min for a total of 38 
cycles. An additional extension step at 72 "C for 7 min 
was then carried out (Mazzocchi et al., 2001). The sizes 
of the amplification products were: OXlR, 328 bp; and 
OX2R 226 bp. To rule out the possibility of amplifying 
genomic DNA, in some experiment PCR was performed 
without prior RT of the RNA. Detection of the PCR 
amplification products was first carried out by size 
fractionation on 2% agarose-gel electrophoresis. After 
purification using the QIA quick PCR purification kit 
(Qiagen, Hilden, Germany), PCR products were 
identified by sequencing on an Alf sequencer 
(Pharmacia Biotech, Freiburg, Germany). 
Animal treatment 
Groups of adult rats with adrenal regeneration, and 
immature animals (n=12) were given three subcutaneous 
injections (28, 16 and 4 h before being sacrificed) of 0.2 
m1 0.9% NaCl where 10 nmollkg body weight of orexin- 
A or orexin-B were disolved. Control rats were injected 
with the saline vehicle. Six animals in each group 
received an intraperitoneal injection of 0.1 mgIl00 g 
vincristine, 180 min before the autopsy. Rats were 328' 
decapitated at 11.00 a.m., and their trunk blood was 
collected in the presence of EDTA (1 mg/ml). Plasma 
was separated and stored at -30 "C. Adrenal glands from 
immature rats and regenerating adrenals were promptly 
removed. 
Corticosterone assay 
Corticosterone was extracted from plasma and 
purified by HPLC (Neri et al. ,  1993), and its 
concentration was measured by radioimmune assay, as 
previously described (Malendowicz et al., 1996). Intra- 
and interassay variation coefficients were 7.1% and 
9.0%, respectively. 
Cell proliferation 
Adrenals were fixed in Bouin's solution for 24 h, 
embedded in paraffin and sectioned at 5-6 pm. Sections 
were stained with hematoxylin and eosin. The metaphase 
index (%o of metaphase-arrested cells) was calculated at 
400, by counting 5,000 cells in the subcapsular zona 
glomerulosa or zona fasciculata of immature adrenals, 
and in the regenerating adrenal parenchyma. 
Statistics 
Data were expressed as means SEM (n = 6). The 
statistical comparison was realized by ANOVA, 
followed by the Multiple Range Test of Duncan. p 
values e 0.05 were considered significant. 
Results 
RT-PCR demonstrated the presence of sizeable 
levels of OXIR and OX2R mRNAs in adult, immature 
and regenerating rat adrenal cortex, the expression of 
both receptors being rather weak in the glands at day 5 
of regeneration (Fig. 1). 
Orexin-A, but not orexin-B, increased (by about 
45%) corticosterone plasma concentration in immature 
rats (Fig. 2, upper panel). Corticosterone blood leve1 was 
higher (about 60%) at day 8 than at day 5 of adrenal 
regeneration, and neither orexin-A nor orexin-B affected 
it (Fig. 2, lower panels). Similar resutls were obtained 
when rats were sacrificed 2 h after the last injection of 
Flg. 1. Ethidium bromide-stained 2% agarose gel showing cDNA 
amplified with rat 0 x 1  R- and OX2R-specific primers frorn RNA of adult 
(AA) and immature adrenal cortex (IA), and adrenocortical tissue at day 
5 (RA5) and 8 of regeneration (RA8). Lane 1 was loaded with 200 ng of 
a size rnarker (Marker VIII, Roche Molecular Biochemicals). The 
amplified fragments were of the expected size, which was 328 bp for 
OXlR and 226 bp for OX2R. No amplification with water instead of 
RNA, as a negative control, is shown in lanes 4, 7 and 10. 
Effects of orexins on adrenals 
orexins, instead of 4 h (data not shown). 
Both orexins significantly raised metaphase index in 
the zona glomerulosa of immature rat adrenals, the effect 
of orexin-B being more intense than that of orexin-A 
(2.7-fold versus 1.5-fold increase) (Fig. 3, upper panel). 
The metaphase index of the zona fasciculata was 
negligible and unaffected by orexins (data not shown). 
The metaphase index was markedly higher (about 2- 
fold) at day 5 than at day 8 of adrenal regeneration. Both 
orexins equipotently evoked a slight decrease (about 
25%) in the metaphase index at day 5, but not at day 8 of 
regeneration (Fig. 3, lower panels). 
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Fig. 2. Effects of orexins on plasma corticosterone concentration in 
immature rats (upper panel) and rats with regenerating adrenal cortex 
(lower panels). Bars are means SEM (n = 6). *: p<0.01 from the 
respective control group. 
Discussion 
Previous studies have shown that both OXIR and 
OX2R are expressed in rat adrenal medulla (Lopez et al., 
1999), and human adrenal cortex and medulla 
(Mazzocchi et al., 2001). Our RT-PCR findings confirm 
the presence of the specific mRNAs for both receptor 
subtypes in adult, immature and regenerating rat adrenal 
glands, thereby making likely the possibility that the 
herein described effects of orexins may be due, at least 
in part, to their direct action on adrenocortical cells. 
Evidence has been provided that the bolus 
administration of orexin-A, but not orexin-B, enhances 
the leve1 of circulating corticosterone in adult rats, by 
controls 
orexin-A 
1 metaphase index [%O]! 
5 days 1 
controls I l  
I 8 days I 
controls 
metaphase index [%O] 
- 
1 I I I 
1 O 20 30 40 50 
Fig. 3. Effects of orexins on the mitotic index of immature (upper panel) 
and regenerating rat adrenal cortex (lower panels). Bars are means 
SEM (n = 6). +: p<0.05 and *: p<0.01, from the respective control value. 
Effects of orexins on adrenals 
stimulating pituitary ACTH release and by acting 
directly on adrenocortical cells (Malendowicz et al., 
1999b). Our present findings confirm that this also 
occurs in immature rats. These authors also showed that 
orexin-B is  much more potent than orexin-A in 
enhancing proliferative activity of adrenal zona 
glomerulosa, the "~ambiu rn '~  layer involved in the 
adrenal enlargement during maturation (for review, see 
Nussdorfer, 1986). 
Orexin-A has high affinity for both OXIR and 
OX2R, while orexin-B possesses a 10-fold higher 
affinity for OX2R than OXIR (De Lecea et al., 1998; 
Sakurai et al., 1998). On these grounds, it may be 
concluded that in immature rat adrenals,  the 
secretagogue effect of orexins is exclusively mediated by 
OXIR, while the proliferogenic action mainly involves 
the activation of OX2R. 
Completely different results have been obtained in 
rats with regenerating rat adrenals, where orexins do not 
affect corticosterone secretion, but lower adrenal 
proliferative activity. The lack of any secretagogue 
action of orexins may reflect a maximal stimulation of 
the regenerating tissue. In fact,  the low levels of 
circulating glucocorticoids, ensuing from the reduced 
mass of regenerating adrenocortical tissue, conceivably 
release hypothalamo-pituitary axis from the negative 
feedback regulating ACTH release (Nussdorfer, 1986). It 
is to be noted that the antiproliferogenic action of 
orexins manifests itself only at day 5 of regeneration, 
when dedifferentiated remanant subcapsular cells display 
a high rate of mitotic activity coupled with a low rate of 
steroid secretion (Taki and Nickerson, 1985; Nussdorfer, 
1986). No histological signs of cell necrosis of apoptosis 
were observed, which seems to exclude that the effect 
was due to a cytotoxic action of orexins at this earlier 
stage of regeneration. Orexins A and B are equipotenent 
in their antiproliferogenic action, thereby suggesting the 
involvement of OX2R. 
Hence, our study seems to suggest that OX2R 
activation mediates opposite effects on the proliferative 
activity of immature and regenerating rat adrenals. This 
puzzling finding may be tentatively explained by taking 
into account that these are two completely different 
models of adrenocortical growth. Immature adrenals 
undergo an almost exclusively ACTH-dependent 
growth, while adrenal regeneration is only partially 
dependent upon pituitary ACTH release; regenerating 
cells resembling the actively proliferating poorly 
differentiated cells forming adrenal cortex during 
embryogenesis (for review, see Engeland et al., 1996; 
Engeland and Levay-Young, 1999). In light of these 
considerations, it could be hypothesized that the orexin- 
induced activation of OX2R, which is  the subtype 
mainly expressed in the hypothalamic nucleus 
paraventricularis (Trivedi et al., 1998), although leading 
to the increase in the release of ACTH by pituitary 
corticotropes, may inhibit the neural pathways mediating 
adrenal growth during regeneration (Dallman, 1985). 
The balance of these two opposite actions could result in 
the depression of the proliferative activity of 
regenerating adrenals. An alternative explanation could 
stem from the recent finding that orexins suppress 
catecholamine synthesis and secretion from cultured 
PC12 cells probably via receptors distinct from the 
classic OXRl and OXR2 (Nanmoku et al., 2000). On 
these grounds, the possibility that orexins exert their 
antiproliferogenic effect on regenerating adrenals acting 
through this novel receptor subtype cannot be excluded 
and await to be investigated. 
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